Session Details

Session Details

08:00 AM - 09:45 AM - Room 327-329

Paola Grandi - PhD, MBA - CG Oncology

Co-Chair

08:00 AM - 09:45 AM - Room 327-329

Richard Vile - PhD - Mayo Clinic

Co-Chair

08:00 AM - 08:15 AM - Room 327-329

Daisuke Morita - MD, PhD - Baylor College of Medicine

359: Additional Expression of T Cell Engager in Clinically Tested Oncolytic Adeno-Immunotherapy Redirects Tumor-Infiltrated, Irrelevant T Cells Against Cancer Cells, Enhancing Anti-Tumor Immunity

08:00 AM - 09:45 AM - Room 327-329

Paola Grandi - PhD, MBA - Adze Biotechnology

Co-Chair

08:15 AM - 08:30 AM - Room 327-329

Georgios Stergiopoulos - MD - Mayo Clinic

360: Repurposing the Selective Serotonin-Reuptake Inhibitor (SSRI) Paroxetine to Combat Systemic Immunosuppression in an Orthotopic Syngeneic Murine Glioblastoma Model Treated with Oncolytic MV-s-NAP-uPA Based Immunovirotherapy

08:30 AM - 08:45 AM - Room 327-329

Steve Thorne - Kalivir Immunotherapeutics

361: The Clinical Oncolytic Virotherapy, VET3-TGI, Displays Potent Therapeutic Activity in Multiple Mouse Tumor Models through Blocking TGF-Beta and Augmenting Type-1 Immune Response

08:45 AM - 09:00 AM - Room 327-329

Benjamin Kendall - Mayo Clinic

362: Where's Waldo: Finding Tumor Antigens in the Circus of the Immune Response to Oncolytic Viruses

09:00 AM - 09:15 AM - Room 327-329

Motomu Nakatake - PhD - Tottori University

363: Anti-Tumor Immune Responses of Oncolytic Vaccinia Virus are Synergistically Enhanced by Induction of Cell-Cell Fusion and Delivery of Multiple Immunomodulators

09:15 AM - 09:30 AM - Room 327-329

Kazuho Inoko - PhD, MD - University of Minnesota

364: Oncolytic Adenovirus Armed with a Type I Interferon Exerts Systemic Antitumor Immunity in Immunocompetent Replication-Permissive Models

09:30 AM - 09:45 AM - Room 327-329

Natalie Elliott - Mayo Clinic

365: Novel Vesiculovirus Library Characterization for Repeat Dosing Strategies